Literature DB >> 19439387

TAT-phiC31 integrase mediates DNA recombination in mammalian cells.

Mao-xiang Zhang1, Zhi-hui Li, Yu-xiang Fang, Huan-zhang Zhu, Jing-lun Xue, Jin-zhong Chen, William Jia.   

Abstract

Streptomyces phage integrase phiC31 is capable of mediating site-specific insertions in mammalian genomes. To avoid potential toxicity of long-term expression of phiC31 in host cells, we developed a method employing a cell-permeable TAT-phiC31 integrase. His6-tagged phiC31 proteins with or without an HIV TAT intercellular transducing peptide were generated and purified. Both of them retained integrase activity in vitro. However, TAT-phiC31 but not phiC31 was able to mediate a specific integration between two att sites in the genome of 293-PB [EGFP] report cell line. Transduced TAT-phiC31 was mainly localized in the cytoplasm that is similar to the localization of phiC31 when expressed through cDNA transfection. Adding a nuclear localization signal (NLS) peptide to the C-terminus of TAT-phiC31 facilitated nuclear localization of the integrase with an increased efficiency of recombination in the reporter cell line. These results demonstrated that TAT can mediate a cell membrane entry of phiC31 protein to perform a site-specific integration in mammalian cells. This is a simple and possibly safer method of site-specific recombination for gene delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439387     DOI: 10.1016/j.jbiotec.2009.03.018

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

1.  LDP12, a novel cell-permeable peptide derived from L1 capsid protein of the human papillomavirus.

Authors:  Jong-Eun Lee; Hyunjung Jade Lim
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

2.  Decreased phospho-Akt signaling in a mouse model of total parenteral nutrition: a potential mechanism for the development of intestinal mucosal atrophy.

Authors:  Yongjia Feng; Jonathan E McDunn; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 3.  Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.

Authors:  George Silva; Laurent Poirot; Roman Galetto; Julianne Smith; Guillermo Montoya; Philippe Duchateau; Frédéric Pâques
Journal:  Curr Gene Ther       Date:  2011-02       Impact factor: 4.391

4.  Improved site-specific recombinase-based method to produce selectable marker- and vector-backbone-free transgenic cells.

Authors:  Yuan Yu; Qi Tong; Zhongxia Li; Jinhai Tian; Yizhi Wang; Feng Su; Yongsheng Wang; Jun Liu; Yong Zhang
Journal:  Sci Rep       Date:  2014-02-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.